We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sigma® Life Science adds 1,400 Cell Lines to its U.S. Portfolio of ECACC® Products
Product News

Sigma® Life Science adds 1,400 Cell Lines to its U.S. Portfolio of ECACC® Products

Sigma® Life Science adds 1,400 Cell Lines to its U.S. Portfolio of ECACC® Products
Product News

Sigma® Life Science adds 1,400 Cell Lines to its U.S. Portfolio of ECACC® Products


Want a FREE PDF version of This Product News?

Complete the form below and we will email you a PDF version of "Sigma® Life Science adds 1,400 Cell Lines to its U.S. Portfolio of ECACC® Products"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

These cell lines have been fully authenticated and tested free of mycoplasma and can now be delivered within days to customers in the U.S., Mexico and Canada. ECACC is a recognized worldwide expert in the maintenance, cultivation and distribution of authenticated cell lines.

Scientists rely upon these cell lines, which include human, mouse and insect, for cell-based assays that determine the safety and efficacy of drug candidates. Due to high costs and the great amount of time required for research and development, drug developers prefer to use cell-based assays in cell signaling studies, cancer research and other areas in order to correct issues that may arise, as early as possible, in the research cycle.

“This is an exciting development for the research community,” said Dr. Bryan Bolton, Commercial Manager at ECACC.  “Sigma Life Science can now provide North American scientists with the benefits of ready access to a complete collection of original ECACC manufactured cell lines, which are fully authenticated using the latest DNA profiling techniques.”
 
Don Finley, Market Segment Manager of Research Cell Culture at Sigma Life Science, said, “We can now serve the global scientific community with a broader range of more easily available ECACC cell lines.  In light of increased interest in cell based research, our plan is to offer an exhaustive collection of high quality cell lines to meet needs of our customers for cell based solutions."

Advertisement